Point-of-Care Test for Assessing Tenofovir Adherence: Feasibility and Recommendations from Women in an Oral PrEP Program in Kenya and Their Healthcare Providers

被引:14
作者
Thuo, Nicholas [1 ]
Polay, Madison [2 ]
Leddy, Anna M. [3 ]
Ngure, Kenneth [1 ,4 ]
Chatterhee, Purba [5 ]
Gandhi, Monica [5 ]
Amico, K. Rivet [2 ]
机构
[1] Kenya Govt Med Res Ctr, Ctr Clin Res, Thika Project, PHRD, Nairobi, Kenya
[2] Univ Michigan, Sch Publ Hlth, Hlth Behav Hlth Educ, Ann Arbor, MI 48109 USA
[3] Univ Calif San Francisco, Dept Med, Div Prevent Sci, San Francisco, CA 94143 USA
[4] Jomo Kenyatta Univ Agr & Technol, Dept Community Hlth, Juja, Kenya
[5] Univ Calif San Francisco, Dept Med, Div HIV Infect Dis & Global Med, San Francisco, CA 94143 USA
关键词
Adherence; Measurement; Urine test; PrEP; TDF; FTC; HIV PREEXPOSURE PROPHYLAXIS; PREVENTION; INFECTION; EFFICACY;
D O I
10.1007/s10461-021-03255-3
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Oral pre-exposure prophylaxis (PrEP) is a highly effective HIV prevention modality when taken as recommended. Women in sub-Saharan Africa may have adherence challenges that remain undisclosed to providers. Real-time measures that identify non-adherence can allow for immediate exploration of adherence challenges, counseling and interventions. We conducted a formative qualitative study in Kenya to explore oral PrEP experiences and reactions to a point-of-care urine test (UT) identifying recent (past 4 days) non-adherence to tenofovir-based PrEP among female PrEP users (25 in-depth interviews; 4 focus groups) and health care provider (10 key informant interviews). Findings indicate that use of the UT would be highly feasible in the context of regular PrEP care, largely acceptable to clients and providers, and could improve adherence. Clients emphasized the need for transparent client-centered strategies in delivering results. This formative study informs the development of tools to implement this point-of-care UT in future interventional studies and clinical settings.
引用
收藏
页码:3617 / 3629
页数:13
相关论文
共 27 条
  • [1] Utility of Different Adherence Measures for PrEP: Patterns and Incremental Value
    Abaasa, Andrew
    Hendrix, Craig
    Gandhi, Monica
    Anderson, Peter
    Kamali, Anatoli
    Kibengo, Freddie
    Sanders, Eduard J.
    Mutua, Gaudensia
    Bumpus, Namandje N.
    Priddy, Frances
    Haberer, Jessica E.
    [J]. AIDS AND BEHAVIOR, 2018, 22 (04) : 1165 - 1173
  • [2] Perspectives of US women participating in a candidate PrEP study: adherence, acceptability and future use intentions
    Amico, K. Rivet
    Ramirez, Catalina
    Caplan, Margaret R.
    Montgomery, Brooke E. E.
    Stewart, Jennifer
    Hodder, Sally
    Swaminathan, Shobha
    Wang, Jing
    Darden-Tabb, Noshima Y.
    McCauley, Marybeth
    Mayer, Kenneth H.
    Wilkin, Timothy
    Landovitz, Raphael J.
    Gulick, Roy
    Adimora, Adaora A.
    [J]. JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2019, 22 (03)
  • [3] Global PrEP roll-out: recommendations for programmatic success
    Amico, K. Rivet
    Bekker, Linda-Gail
    [J]. LANCET HIV, 2019, 6 (02): : E137 - E140
  • [4] Experiences with HPTN 067/ADAPT Study-Provided Open-Label PrEP Among Women in Cape Town: Facilitators and Barriers Within a Mutuality Framework
    Amico, K. Rivet
    Wallace, Melissa
    Bekker, Linda-Gail
    Roux, Surita
    Atujuna, Millicent
    Sebastian, Elaine
    Dye, Bonnie J.
    Elharrar, Vanessa
    Grant, Robert M.
    [J]. AIDS AND BEHAVIOR, 2017, 21 (05) : 1361 - 1375
  • [5] Self-reported Recent PrEP Dosing and Drug Detection in an Open Label PrEP Study
    Amico, K. Rivet
    Mehrotra, Megha
    Avelino-Silva, Vivian I.
    McMahan, Vanessa
    Veloso, Valdilea G.
    Anderson, Peter
    Guanira, Juan
    Grant, Robert
    [J]. AIDS AND BEHAVIOR, 2016, 20 (07) : 1535 - 1540
  • [6] What Can Urine Tell Us About Medication Adherence?
    Anderson, Peter L.
    [J]. ECLINICALMEDICINE, 2018, 2-3 : 5 - 6
  • [7] [Anonymous], Winning Reform in the States: Blueprints 2017 Update
  • [8] Pharmacologic-Based Methods of Adherence Assessment in HIV Prevention
    Brooks, Kristina M.
    Anderson, Peter L.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2018, 104 (06) : 1056 - 1059
  • [9] Participants' Explanations for Nonadherence in the FEM-PrEP Clinical Trial
    Corneli, Amy
    Perry, Brian
    McKenna, Kevin
    Agot, Kawango
    Ahmed, Khatija
    Taylor, Jamilah
    Malamatsho, Fulufhelo
    Odhiambo, Jacob
    Skhosana, Joseph
    Van Damme, Lut
    [J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2016, 71 (04) : 452 - 461
  • [10] PrEP Adherence Patterns Strongly Affect Individual HIV Risk and Observed Efficacy in Randomized Clinical Trials
    Dimitrov, Dobromir T.
    Masse, Benoit R.
    Donnell, Deborah
    [J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2016, 72 (04) : 444 - 451